Since small molecules that bind directly to PIWIL1 and alter its function have not yet been achieved, targeting the signaling pathways that contribute to PIWIL1 dysregulation has been exploited as new approaches to treat PIWIL1-expressing cancers (Reeves et al., 2012; Herr et al., 2015). The gene discussed is PIWIL1; the disease is cancer.